INTRODUCTION
Several lines of evidence suggest that serotonergic dysfunction is involved in the susceptibility to suicide. A low level of 5-hydroxyindoleacetic acid, the principal metabolite of serotonin, in cerebrospinal fluid and a blunted prolactin response to fenfluramine, which indicates serotonergic hypofunction in the brain, have been found in subjects with suicidal behavior. 1, 2 These findings seem to be independent of psychiatric diagnoses and to correlate with the lethality of suicide attempts. Thus, suicide is explained by factors other than the presence of a specific psychiatric disorder. 3 Family, twin, and adoption studies have shown that genetic factors partly explain the risks for suicide. 4 Genetic variations in the serotonergic system are thought to affect serotonin turnover, 5 the density of serotonin transporters (5-HTT), 6 and the levels of tryptophan hydroxylase (TPH), 7 which is the rate-limiting enzyme in serotonin biosynthesis. Therefore, a functional alteration of serotonergic neurotransmission due to gene polymorphisms might lead to serotonergic dysfunction, which could contribute to suicidal behavior. Over the last years, a growing number of molecular genetic studies carried out investigating an association between suicidal behavior and a genetic variant in serotonergic candidate genes, particularly TPH, 5-HTT, monoamine oxidase A, serotonin 2A, 1A and 1B receptor genes. [7] [8] [9] [10] [11] [12] [13] Studies on the 18 were also found to reduce the rates of attempted and/or completed suicides in patients with schizophrenia.
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If 5-HT 6 receptors have a role in the biological susceptibility to suicidal behavior, it may be due to polymorphisms in the 5-HT 6 Five other variants of the 5-HT 6 receptor gene have been described in a German population, but they were not examined in this study because one of the five variants was in complete linkage disequilibrium with 6 267C/T polymorphism, the other four variants had very low allele frequencies, and none involved changes in the amino acid sequence. 25 To explore the hypothesis that the 5-HT 6 receptor gene is involved in the susceptibility to suicide, we examined whether 267C/T and (GCC) 2/3 polymorphisms are associated with suicide victims.
METHODS
The 
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Target sequences were amplified by PCR using primers 5'-CCC GTT GTG AGT GGG CAG CAC C-3' and 5'-CCT CCC AAC CCA CAC GTG GCT GC-3' (a mismatched nucleotide is underlined). PCR products were digested with FspⅠ at 37℃ for 4 hr and then electrophoresed on 4% agarose gels. The (GCC) 2 allele showed PCR fragments of 84 bp and 23 bp, whereas the (GCC) 3 allele PCR product remained uncut with a PCR fragment size of 110 bp.
The genotype distribution and Hardy-Weinberg equilibrium were tested by chi-square test for goodness of fit. Comparisons of the genotype frequencies and allele frequencies between the two groups were performed using a chi-square test and a two-8 tailed Fisher's exact test, respectively. Haplotype frequencies were estimated from genotypic data by the maximum-likelihood method using the LDSUPPORT program. 26 The P level of significance retained was 0.05.
RESULTS
The samples of 163 suicide victims and 166 controls were genotyped for There was also no difference in genotype distribution or allele frequency of the two polymorphisms after stratification by gender (data not shown).
Maximum likelihood analysis of haplotype distributions (Table 2) demonstrated the presence of tight linkage disequilibrium between the two 9 polymorphisms in both groups (P < 0.0001). No significant difference was found in the haplotype distributions between the two groups (χ 2 = 0.738, d.f. = 3, P = 0.864).
DISCUSSION
In this study, no association was found between the 267C/T polymorphism and suicide victims. Recently, we learned of a similar study by Turecki et al., 27 in which no association was found between the 267C/T polymorphism and suicide completion in a Caucasian population. Our result is consistent with the results of Turecki et al. 27 To our knowledge, our study is the first association study of the trinucleotide repeat polymorphism, (GCC) 2/3 , in the 5'-upstream region of the 5-HT 6 receptor gene in suicide completers. Although it is possible that the (GCC) 2/3 polymorphism affects transcriptional regulation, the physiological function of this polymorphism remains unclear. In this study, no association was found between the (GCC) 2/3 polymorphism and suicide victims. In the 267C/T and (GCC) 2/3 polymorphisms, the genotype and allele distributions in this study were almost consistent with those previously reported by Shinkai et al. 28 and Ohmori et al. 24 respectively. Moreover, the two polymorphisms were in tight linkage disequilibrium and the haplotype distribution of the 5-HT 6 receptor gene in suicide victims was not different from that of the controls. The present findings in a Japanese population could 10 not support our hypothesis that the 5-HT 6 receptor gene is involved in the susceptibility to suicide.
Positive associations were found between the 267T allele and schizophrenia, 29 and between the 267C allele and bipolar affective disorder, 25 but other studies 28, 30 did not find an association between the 5-HT 6 receptor gene and either schizophrenia or affective disorder. Thus, the results are still far inconclusive about the association of 5-HT 6 receptor gene with specific psychiatric disorders.
This study has some limitations. First, psychiatric diagnoses were not available in this study under our ethical code for genetic studies. We cannot exclude the possibility that psychiatric diagnoses of suicide completers would have affected our results. Second, the sample size of the subjects enrolled may be insufficient. The sample has a power of 1.00 to detect a medium effect size (w = 0.30) and of 0.73 to detect a small effect size (w = 0.10) at the P<0.05 level for allele comparison. This means that the present study may fail to detect small effects of these polymorphisms on suicide due to a type Ⅱ error. Third, haplotype map approaches were not applied. 31 In the present study, our results do not provide any evidence that the 5-HT 6 receptor gene is involved in the susceptibility to suicide. To clarify the serotonergic dysfunction in suicide by molecular genetic approaches, further studies should plan for larger samples, multi-SNP haplotype analysis and association studies of other 
